Zobrazeno 1 - 10
of 537
pro vyhledávání: '"John Brazier"'
Autor:
Matthew Franklin, Francis Shupo, Grace Wayi-Wayi, Natasa Zibelnik, Emily Jones, Nicola Mason, John Brazier, Sudipto Mukherjee
Publikováno v:
Oncology and Therapy, Vol 12, Iss 3, Pp 491-508 (2024)
Abstract Introduction Idiopathic multicentric Castleman disease (iMCD) is a rare, chronic, debilitating lymphoproliferative disorder where the mainstay of treatment is symptom management. Our recent international patient survey showed that patients w
Externí odkaz:
https://doaj.org/article/2e1b76a676c34735bda2a0626d7a24ce
Autor:
Ed Hawkins, Stephen Burt, Mark McCarthy, Conor Murphy, Catherine Ross, Mike Baldock, John Brazier, Gill Hersee, Jacqui Huntley, Richard Meats, John O’Grady, Ian Scrimgeour, Tim Silk
Publikováno v:
Geoscience Data Journal, Vol 10, Iss 2, Pp 246-261 (2023)
Abstract Recovering additional historical weather observations from known archival sources will improve the understanding of how the climate is changing and enable detailed examination of unusual events within the historical record. The UK National M
Externí odkaz:
https://doaj.org/article/62b0973831ea436399771f48256e1ea4
Autor:
Sudipto Mukherjee, Francis Shupo, Grace Wayi-Wayi, Natasa Zibelnik, Emily Jones, Nicola Mason, Matthew Franklin, John Brazier
Publikováno v:
EClinicalMedicine, Vol 64, Iss , Pp 102192- (2023)
Summary: Background: Idiopathic Multicentric Castleman Disease (iMCD) is a rare inflammatory lymphoproliferative disorder with heterogenous clinical presentations. The symptomatology in iMCD patients remains poorly understood. The aim of this study w
Externí odkaz:
https://doaj.org/article/f60a4f73ab904812b44261352373f2a9
Autor:
Matt Franklin, Francis Shupo, Emily Jones, Nicola Mason, Grace Wayi-Wayi, Karan Kanhai, Natasa Zibelnick, Mileva Repasky, Kelly Makarounas-Kirchmann, Sudipto Mukherjee, John Brazier
Publikováno v:
HemaSphere, Vol 7, p e69432f9 (2023)
Externí odkaz:
https://doaj.org/article/20c8c50023504171b35f1e6c71d49a27
Autor:
Lynne Broderick, Jakob B. Bjorner, Miranda Lauher-Charest, Michelle K. White, Mark Kosinski, Brendan Mulhern, John Brazier
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 6, Iss 1, Pp 1-15 (2022)
Abstract Background The SF-6Dv2 classification system assesses health states in six domains—physical functioning, role function, bodily pain, vitality, social functioning, and mental health. Scores have previously been derived from the SF-36v2® He
Externí odkaz:
https://doaj.org/article/7a24f88041e447f197e2f174c85b190b
Publikováno v:
BMJ Global Health, Vol 7, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/43ae2db7270d45ee992897fedbaf3f68
Publikováno v:
Wellcome Open Research, Vol 7 (2022)
Introduction Standard valuation methods, such as TTO and DCE are inefficient. They require data from hundreds if not thousands of participants to generate value sets. Here, we present the Online elicitation of Personal Utility Functions (OPUF) tool;
Externí odkaz:
https://doaj.org/article/997c02394322487dbea2e99e6cdc8230
Autor:
Philip Hykin, A Toby Prevost, Sobha Sivaprasad, Joana C Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Abualbishr Alshreef, Laura Flight, Rebekah Pennington, Barry Hounsome, Ellen Lever, Andrew Metry, Edith Poku, Yit Yang, Simon P Harding, Andrew Lotery, Usha Chakravarthy, John Brazier
Publikováno v:
Health Technology Assessment, Vol 25, Iss 38 (2021)
Background: Licensed ranibizumab (0.5 mg/0.05 ml Lucentis®; Novartis International AG, Basel, Switzerland) and aflibercept (2 mg/0.05 ml Eylea®; Bayer AG, Leverkusen, Germany) and unlicensed bevacizumab (1.25 mg/0.05 ml Avastin®; F. Hoffmann-La Ro
Externí odkaz:
https://doaj.org/article/e5f5366ffc58403b87cc8c40698ab4e5
Autor:
Andrew Grundy, Anju Devianee Keetharuth, Rosemary Barber, Jill Carlton, Janice Connell, Elizabeth Taylor Buck, Michael Barkham, Thomas Ricketts, Dan Robotham, Diana Rose, John Kay, Rob Hanlon, John Brazier
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background To provide a model for Public involvement (PI) in instrument development and other research based on lessons learnt in the co-production of a recently developed mental health patient reported outcome measure called Recovering Qual
Externí odkaz:
https://doaj.org/article/eb5d3f9927a34aecb3c9bc9e85abdb46
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Duchenne Muscular Dystrophy (DMD) is a severe, life-limiting and incurable condition. However, studies estimating quality of life and those measuring actual quality of life in people living with DMD vary considerably. This discrepancy indica
Externí odkaz:
https://doaj.org/article/a349bc77196443998ab3bf8facc3e2fb